F
FogPharma
1 follower
FogPharma is dedicated to the creation of a new class of medicines that target human disease drivers currently considered “undruggable.” The company’s cell-penetrating miniproteins (CPMPs) combine the targeting power of protein therapeutics with the cell-penetrating ability of small molecules. This... Read more
Org chart
Mathai Mammen
Advisor & CEO Designate
Keith Orford
CMO & EVP, Clinical & Translational Sciences
Sandra Smith
VP, Head of People
John Mcgee
VP, De Novo Discovery
Thomas Kotarako
SVP, Finance
Kristen Stants
Chief People Officer
Dave Varon
Principal Data Engineer
Amanda Garofalo
Senior Director Clinical Operations
John Doherty
Head Of Facility
Ashley Kancler
Senior Administrative Business Partner
Board & advisors
Corey Goodman
Chairman
Barbara Weber
Director
Edward Fitzgerald
Director
Jeffrey Leerink
Director
Krishna Yeshwant
Director
Thomas Gajewski
Advisor
Keith Flaherty
Advisor
Fernando Camargo
Advisor
David Scadden
Advisor
Teams
Offices
Similar companies
Sutro Biopharma
3 followers
Active Motif
3 followers
Xeris Pharmaceuticals
2 followers
AbbVie
223 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
1 follower
Amgen
244 followers
Elanco
23 followers
Eikon Therapeutics
2 followers
Cosette Pharmaceuticals
1 follower
Bristol-Myers Squibb
222 followers
Explore companies